A lot of money is sloshing around, and medical device start-ups are reaping the benefits.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Interrupting transmission of the virus is the goal for Becton Dickinson.
In the second half of 2020 medtech began a tentative – and possibly short-lived – recovery.
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
A new UK plan to use antigen tests for wide-scale screening for Covid-19 may not be the easy win the government is seeking.